IT1267955B1 - Derivati solfatati dei lisogangliosidi - Google Patents

Derivati solfatati dei lisogangliosidi

Info

Publication number
IT1267955B1
IT1267955B1 IT93PD000044A ITPD930044A IT1267955B1 IT 1267955 B1 IT1267955 B1 IT 1267955B1 IT 93PD000044 A IT93PD000044 A IT 93PD000044A IT PD930044 A ITPD930044 A IT PD930044A IT 1267955 B1 IT1267955 B1 IT 1267955B1
Authority
IT
Italy
Prior art keywords
gangliosides
lyso
sulfonyl
poly
dilyso
Prior art date
Application number
IT93PD000044A
Other languages
English (en)
Inventor
Aurelio Romeo
Gunter Kirschner
Carlo Chizzolini
Hari Manev
Laura Facci
Original Assignee
Fidia S P A In Amministrazione
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia S P A In Amministrazione filed Critical Fidia S P A In Amministrazione
Publication of ITPD930044A0 publication Critical patent/ITPD930044A0/it
Priority to IT93PD000044A priority Critical patent/IT1267955B1/it
Priority to AT94911404T priority patent/ATE202112T1/de
Priority to DE69427468T priority patent/DE69427468T2/de
Priority to US08/530,267 priority patent/US5795869A/en
Priority to CA002157357A priority patent/CA2157357A1/en
Priority to PCT/US1994/001966 priority patent/WO1994020516A1/en
Priority to ES94911404T priority patent/ES2157257T3/es
Priority to EP94911404A priority patent/EP0688331B1/en
Priority to AU63935/94A priority patent/AU685787B2/en
Priority to JP6520042A priority patent/JPH08507308A/ja
Publication of ITPD930044A1 publication Critical patent/ITPD930044A1/it
Application granted granted Critical
Publication of IT1267955B1 publication Critical patent/IT1267955B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT93PD000044A 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi IT1267955B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT93PD000044A IT1267955B1 (it) 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi
CA002157357A CA2157357A1 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives
DE69427468T DE69427468T2 (de) 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate
US08/530,267 US5795869A (en) 1993-03-04 1994-03-04 Sulfated lyso-ganglioside derivatives
AT94911404T ATE202112T1 (de) 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate
PCT/US1994/001966 WO1994020516A1 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives
ES94911404T ES2157257T3 (es) 1993-03-04 1994-03-04 Nuevos derivados liso-gangliosidos sulfatados.
EP94911404A EP0688331B1 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives
AU63935/94A AU685787B2 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives
JP6520042A JPH08507308A (ja) 1993-03-04 1994-03-04 新規硫酸化リゾ−ガングリオシド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93PD000044A IT1267955B1 (it) 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi

Publications (3)

Publication Number Publication Date
ITPD930044A0 ITPD930044A0 (it) 1993-03-04
ITPD930044A1 ITPD930044A1 (it) 1994-09-04
IT1267955B1 true IT1267955B1 (it) 1997-02-18

Family

ID=11390208

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93PD000044A IT1267955B1 (it) 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi

Country Status (9)

Country Link
EP (1) EP0688331B1 (it)
JP (1) JPH08507308A (it)
AT (1) ATE202112T1 (it)
AU (1) AU685787B2 (it)
CA (1) CA2157357A1 (it)
DE (1) DE69427468T2 (it)
ES (1) ES2157257T3 (it)
IT (1) IT1267955B1 (it)
WO (1) WO1994020516A1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi

Also Published As

Publication number Publication date
EP0688331B1 (en) 2001-06-13
ES2157257T3 (es) 2001-08-16
ATE202112T1 (de) 2001-06-15
JPH08507308A (ja) 1996-08-06
WO1994020516A1 (en) 1994-09-15
AU6393594A (en) 1994-09-26
AU685787B2 (en) 1998-01-29
CA2157357A1 (en) 1994-09-15
ITPD930044A0 (it) 1993-03-04
EP0688331A1 (en) 1995-12-27
DE69427468T2 (de) 2002-04-18
DE69427468D1 (de) 2001-07-19
ITPD930044A1 (it) 1994-09-04

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ATE303127T1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
ZA895840B (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
SE9400524D0 (sv) Energipreparat
ATE202112T1 (de) Neue sulfatierte lyso-gangliosidederivate
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
ATE181669T1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
DE69323191D1 (de) Wasserlösliche retinoide
PL304666A1 (en) Peptides of organoprotective activity, method of obtaining them and their application in therapy

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990210